- Home
- TFIN vs ARWR Comparison
TFIN vs ARWR Comparison
Compare TFIN & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- ARWR
- Stock Information
- Founded
- TFIN 1981
- ARWR 2003
- Country
- TFIN United States
- ARWR United States
- Employees
- TFIN N/A
- ARWR N/A
- Industry
- TFIN Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- TFIN Finance
- ARWR Health Care
- Exchange
- TFIN Nasdaq
- ARWR Nasdaq
- Market Cap
- TFIN 1.5B
- ARWR 1.7B
- IPO Year
- TFIN N/A
- ARWR 1993
- Fundamental
- Price
- TFIN $51.50
- ARWR $12.08
- Analyst Decision
- TFIN Hold
- ARWR Buy
- Analyst Count
- TFIN 6
- ARWR 11
- Target Price
- TFIN $77.50
- ARWR $41.44
- AVG Volume (30 Days)
- TFIN 208.4K
- ARWR 1.7M
- Earning Date
- TFIN 04-16-2025
- ARWR 05-08-2025
- Dividend Yield
- TFIN N/A
- ARWR N/A
- EPS Growth
- TFIN N/A
- ARWR N/A
- EPS
- TFIN 0.54
- ARWR N/A
- Revenue
- TFIN $396,285,000.00
- ARWR $2,500,000.00
- Revenue This Year
- TFIN $17.60
- ARWR $4,380.43
- Revenue Next Year
- TFIN $12.72
- ARWR $58.72
- P/E Ratio
- TFIN $96.02
- ARWR N/A
- Revenue Growth
- TFIN N/A
- ARWR N/A
- 52 Week Low
- TFIN $51.47
- ARWR $11.61
- 52 Week High
- TFIN $110.58
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- TFIN 23.20
- ARWR 27.72
- Support Level
- TFIN $56.50
- ARWR $14.69
- Resistance Level
- TFIN $59.53
- ARWR $15.65
- Average True Range (ATR)
- TFIN 2.68
- ARWR 0.75
- MACD
- TFIN -0.26
- ARWR -0.16
- Stochastic Oscillator
- TFIN 0.70
- ARWR 11.15
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.